NOMAD POWER SOLUTIONS, INC.
NMAD · XNASCIK 1335105fmd_1Y61BG44W9D09WR8TT3KBDHZ4FManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Jun 30, 2026, 69 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | – | – | – |
| Cost of revenue | 0 | – | – | – | – | – | – | – | – | – |
| Gross profit | – | – | – | – | – | – | – | – | – | – |
| Research and development | 1 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 0 |
| Total operating expenses | 2 | 2 | 2 | 2 | 3 | 7 | 6 | 5 | 4 | 5 |
| Operating income | (2) | (2) | (2) | (2) | (3) | (7) | (6) | (5) | (4) | (5) |
| Interest expense | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Income tax expense | – | – | – | – | – | – | – | – | – | 0 |
| Net income | (2) | (2) | (2) | (2) | (3) | (7) | (6) | (5) | (4) | (6) |
| Net income to common shareholders | (2) | – | – | – | – | – | – | – | – | – |